Date Closed

December 12, 2022

Lead Office

Québec City

Value

50.00 Million USD

On December 12, 2022, Aptose Biosciences Inc. (“Aptose”) has entered into an equity distribution agreement with JonesTrading Institutional Services LLC, as agent, pursuant to which Aptose may, from time to time, issue and sell common shares of Aptose through “at-the-market” distributions on the Nasdaq Capital Market. The common share offering will be by way of prospectus supplement and of an aggregate offering price of up to US$50 million.

Aptose, headquartered in Toronto, Ontario, is a biopharmaceutical company. It focuses on the discovery, research and development of anti-cancer therapies. 

McCarthy Tétrault assisted Aptose with a team led by Charles-Antoine Souliere that includes Annie Poirier-Simard, Valérie Trudeau and Isabelle Chouinard (Business).